Management of Basal Cell Adenoma of Parotid Gland with Blair's Incision

Forfattere

  • Sushant Parbat Department of Oral and Maxillofacial Surgery, Bharati Vidyapeeth Deemed University Dental College and Hospital, Pune, Maharashtra, India
  • Bhawana Narla Department of Oral and Maxillofacial Surgery, Bharati Vidyapeeth Deemed University Dental College and Hospital, Pune, Maharashtra, India
  • Shandilya Ramanojam Department of Oral and Maxillofacial Surgery, Bharati Vidyapeeth Deemed University Dental College and Hospital, Pune, Maharashtra, India
  • Gadre K. S Department of Oral and Maxillofacial Surgery, Bharati Vidyapeeth Deemed University Dental College and Hospital, Pune, Maharashtra, India
  • Sujay Patil Department of Oral and Maxillofacial Surgery, Bharati Vidyapeeth Deemed University Dental College and Hospital, Pune, Maharashtra, India

Resumé

A basal cell adenoma (BCA) of salivary gland origin is a rare tumour which was included as a separate salivary gland tumour in the classification schemes by the World Health Organization (WHO) in 1991. It is an uncommon benign salivary gland epithelial tumor which accounts for 1–2% of all salivary gland epithelial tumors and more than 80% of BCAs arises in the major salivary glands, mostly the parotid gland. It is usually firm in consistency, mobile, slow growing mass, and tends to be multiple. In this article we would like to report a case of BCA which was managed uneventfully by preserving the facial nerve and its branches.  Keywords:  Basal cell adenoma (BCA), parotid gland, benign tumor, Blair's incision, facial nerveCite this Article Parbat S, Narla B, Ramanojam S, et al. Management of Basal Cell Adenoma of Parotid Gland with Blair's Incision. Research & Reviews: Journal of Dentistry. 2017; 8(1): 9–12p.

Downloads

Publiceret

2017-04-14

Nummer

Årg. 8 Nr. 1 (2017)

Sektion

Case Study

Licens

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.